Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Clinical trial NCT02278120 · COMPLETED
Trial details
- NCT number
- NCT02278120
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-20
- Primary completion
- 2017-08-21
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.